semaglutide and cardiovascular outcomes in patients with type 2 diabetes Series: outcome trials for drugs SUSTAIN-6 Effect of once-weekly subcutaneous semaglutide – Semaglutide reduced the risk of

To avoid dosing errors and potential overdose, instruct patients to never use a syringe to remove TOUJEO from the TOUJEO SoloStar or TOUJEO Max SoloStar single-patient-use prefilled pen [see Warnings and Precautions (5.4)]

Take the cap off the needle, being careful not to touch the needle to keep it sterile

Although further research is needed regarding its long-term safety, a daily intake of up to 2g for a few months does not appear to cause health issues but primarily provides benefits

During testing, the app couldnt be downloaded because it was listed as unavailable in our region

Oral Formulation The oral formulation consists of the following doses: 3 mg 7 mg 14 mg You will observe that these doses are significantly higher than that of semaglutide injection